Beta Bionics Takes Bold Step with $204 Million IPO, Paving the Way for Diabetes Innovation,
Beta Bionics Aims for Growth with $204 Million IPO: A New Era in Diabetes ManagementIn a bold move signaling its ambitions for expansion, Beta Bionics, Inc. headquartered in Irvine, California, has announced the pricing...
Jan 30, 2025
Management Announcement